Calling all immunitybio, inc. (ibrx) investors: contact bronstein, gewirtz & grossman, llc today!

New york , july 5, 2023 /prnewswire/ -- attorney advertising-- bronstein, gewirtz & grossman, llc, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against immunitybio, inc. ("immunitybio" or the "company") (nasdaq: ibrx) and certain of its officers. class definition: this lawsuit seeks to recover damages against defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired immunitybio securities between may 23, 2022 and may 10, 2023, inclusive (the "class period").
IBRX Ratings Summary
IBRX Quant Ranking